TiNT Statistical Analysis Plan v2.0
TiNT: Trametinib in Neurofibromatosis type 1 associated tumours
A phase II study of trametinib in paediatric, adolescent and young adult patients with neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas
Statistical Analysis Plan
History
MCRI Data Classification
- Public
